Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3988)
All Articles published online
|
Jun 1, 2004 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tangkijvanich P, Mahachai V, Suwangool P, Poovorawan Y. Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma. World J Gastroenterol 2004; 10(11): 1547-1550 [PMID: 15162522 DOI: 10.3748/wjg.v10.i11.1547] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i11/1547.htm |
| Number | Citing Articles |
| 1 |
Nicole E. Rich, Caitlin C. Murphy, Adam C. Yopp, Jasmin Tiro, Jorge A. Marrero, Amit G. Singal. Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2020; 52(4): 701 doi: 10.1111/apt.15917
|
| 2 |
Yan Li, Hankun Li, Jan M. Spitsbergen, Zhiyuan Gong. Males develop faster and more severe hepatocellular carcinoma than females in krasV12 transgenic zebrafish. Scientific Reports 2017; 7(1) doi: 10.1038/srep41280
|
| 3 |
Maya R Ladenheim, Nathan G Kim, Pauline Nguyen, An Le, Marcia L Stefanick, Gabriel Garcia, Mindie H Nguyen. Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study. BMJ Open Gastroenterology 2016; 3(1): e000107 doi: 10.1136/bmjgast-2016-000107
|
| 4 |
Suzan Attia Mawed, Yan He, Jin Zhang, Jie Mei. Strategy of Hepatic Metabolic Defects Induced by beclin1 Heterozygosity in Adult Zebrafish. International Journal of Molecular Sciences 2020; 21(4): 1533 doi: 10.3390/ijms21041533
|
| 5 |
Elena Buzzetti, Pathik M. Parikh, Alessio Gerussi, Emmanuel Tsochatzis. Gender differences in liver disease and the drug-dose gender gap. Pharmacological Research 2017; 120: 97 doi: 10.1016/j.phrs.2017.03.014
|
| 6 |
Shama C. Buch, Venkateswarlu Kondragunta, Robert A. Branch, Brian I. Carr. Gender-based outcomes differences in unresectable hepatocellular carcinoma. Hepatology International 2008; 2(1): 95 doi: 10.1007/s12072-007-9041-2
|
| 7 |
Matteo Garcovich, Andrew Kenneth Burroughs. Sex and Gender Aspects in Clinical Medicine. 2012; : 65 doi: 10.1007/978-0-85729-832-4_6
|
| 8 |
Dun‐Chang Mo, Jian‐Feng Huang, Shang‐Xiao Huang, Han‐Lei Wang, Peng‐Hui Luo. Letter: female patients with hepatocellular carcinoma may have better prognosis than male patients. Alimentary Pharmacology & Therapeutics 2020; 52(11-12): 1769 doi: 10.1111/apt.16099
|
| 9 |
Chi Ming Lam, Jamy L Yong, Annie O Chan, Kelvin K Ng, Ronnie T Poon, Chi Leung Liu, Chung Mau Lo, Sheung Tat Fan. Better Survival in Female Patients With Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 2005; 39(6): 533 doi: 10.1097/01.mcg.0000165670.25272.46
|
| 10 |
Khalid A. Alswat, Faisal M. Sanai, Mansour Altuwaijri, Ali Albenmousa, Majid Almadi, Waleed K. Al-Hamoudi, Ayman A. Abdo. Clinical Characteristics of Patients with Hepatocellular Carcinoma in a Middle Eastern Population. Hepatitis Monthly 2013; 13(5) doi: 10.5812/hepatmon.7612
|
| 11 |
Erica Villa. Role of Estrogen in Liver Cancer. Women's Health 2008; 4(1): 41 doi: 10.2217/17455057.4.1.41
|
| 12 |
Miu Mizuhata, Shigeyuki Takamatsu, Satoshi Shibata, Sayuri Bou, Yoshitaka Sato, Mariko Kawamura, Satoko Asahi, Yuji Tameshige, Yoshikazu Maeda, Makoto Sasaki, Tomoyasu Kumano, Satoshi Kobayashi, Kazutaka Yamamoto, Hiroyasu Tamamura, Toshifumi Gabata. Respiratory-Gated Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract without Fiducial Markers. Cancers 2018; 10(2): 58 doi: 10.3390/cancers10020058
|
| 13 |
Yuanchen Cheng, Ming Feng. A rare case of pituitary metastasis from hepatocellular carcinoma: case report and literature review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1227678
|
| 14 |
Jie Zhao, Yin Sun, Hui Lin, Fuju Chou, Yao Xiao, Ren'an Jin, Xiujun Cai, Chawnshang Chang. Olaparib and enzalutamide synergistically suppress HCC progression via the AR‐mediated miR‐146a‐5p/BRCA1 signaling. The FASEB Journal 2020; 34(4): 5877 doi: 10.1096/fj.201903045RR
|
| 15 |
Cheng-Yen Liao, Chun-Yang Lee, Cheng-Yi Wei, Yee Chao, Yi-Hsiang Huang, Ming-Chih Hou, Yu-Hui Su, Jaw-Ching Wu, Chien-Wei Su. Differential prognoses among male and female patients with hepatocellular carcinoma. Journal of the Chinese Medical Association 2022; 85(5): 554 doi: 10.1097/JCMA.0000000000000722
|
| 16 |
Hassam Ali, Fnu Vikash, Vishali Moond, Fatima Khalid, Abdur Rehman Jamil, Dushyant Singh Dahiya, Amir Humza Sohail, Manesh Kumar Gangwani, Pratik Patel, Sanjaya K Satapathy. Global trends in hepatitis C-related hepatocellular carcinoma mortality: A public database analysis (1999-2019). World Journal of Virology 2024; 13(1): 89469 doi: 10.5501/wjv.v13.i1.89469
Abstract(330) |
Core Tip(387) |
Full Article(HTML)(1725)
|
Full Article with Cover (PDF)-5502K(72)
|
Full Article (Word)-870K(4)
|
Audio-1152K(6)
|
Peer-Review Report-194K(41)
|
Answering Reviewers-195K(47)
|
Full Article (PDF)-2903K(94)
|
Full Article (XML)-263K(36)
|
Times Cited (1)
|
Total Visits (4557)
|
Open
|
| 17 |
Lei Zhang, JinFeng Wu, QiuMei Wu, XiangJuan Zhang, ShuaiCai Lin, WanLi Ran, Li Zhu, ChengYan Tang, Xing Wang. Sex steroid axes in determining male predominance in hepatocellular carcinoma. Cancer Letters 2023; 555: 216037 doi: 10.1016/j.canlet.2022.216037
|
| 18 |
Anke Zhang, Ling Yuan, Shaojian Lin, Houshi Xu, Meiqing Lou, Yajun Xue, Yuanzhi Xu. Symptomatic pituitary metastasis from hepatocellular carcinoma: a case report and literature review. All Life 2021; 14(1): 691 doi: 10.1080/26895293.2021.1955753
|
| 19 |
Robert G. Gish. Hepatocellular Carcinoma: Overcoming Challenges in Disease Management. Clinical Gastroenterology and Hepatology 2006; 4(3): 252 doi: 10.1016/j.cgh.2006.01.001
|
| 20 |
Ibraheim Ahmed Diab, Shaimaa Abdel-hamid Hassanein, Hala Hafez Mohamed. Comparison between C-arm cone beam computed tomography and interventional angiography in transarterial chemoembolization of hepatocellular carcinoma. Egyptian Journal of Radiology and Nuclear Medicine 2019; 50(1) doi: 10.1186/s43055-019-0053-4
|
| 21 |
Min Du, Lingli Chen, Jing Zhao, Feng Tian, Haiying Zeng, Yunshan Tan, Huichuan Sun, Jian Zhou, Yuan Ji. Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-38
|
| 22 |
Nehad Hawash, Reham Gameaa, Doaa Elwy, Shimaa Mansour. Red Blood Cell Distribution Width as a Diagnostic Marker of Hepatocellular Carcinoma in Cirrhotic Patients. The Open Biomarkers Journal 2024; 14(1) doi: 10.2174/0118753183275959231129064650
|
| 23 |
Bryce D. Beutler, Mark B. Ulanja, Rohee Krishan, Vijay Aluru, Munachismo L. Ndukwu, Molly M. Hagen, Zachary D. Dupin, Charles E. Willyard, Alastair E. Moody, Killian Boampong-Konam, Steven C. Zell. Sociodemographic Characteristics as Predictors of Outcomes in Hepatocellular Carcinoma: A Retrospective Cohort Study. Cancer Control 2020; 27(1) doi: 10.1177/1073274820956615
|
| 24 |
Zhuona Rong, Tingting Fan, Huiling Li, Juan Li, Kangwei Wang, Xinxin Wang, Jianyi Dong, Jun Chen, Fujin Wang, Jingyu Wang, Aiguo Wang. Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice. Molecular & Cellular Proteomics 2017; 16(8): 1475 doi: 10.1074/mcp.M116.065474
|
| 25 |
Shiou‐Hwei Yeh, Chi‐Ming Chiu, Chi‐Ling Chen, Shu‐Fen Lu, Hey‐Chi Hsu, Ding‐Shinn Chen, Pei‐Jer Chen. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma. International Journal of Cancer 2007; 120(8): 1610 doi: 10.1002/ijc.22479
|
| 26 |
Wenzhuan He, Fangxiang Chen, Brian Dalm, Patricia A. Kirby, Jeremy D. W. Greenlee. Metastatic involvement of the pituitary gland: a systematic review with pooled individual patient data analysis. Pituitary 2015; 18(1): 159 doi: 10.1007/s11102-014-0552-2
|
| 27 |
Eva Sonnenberg-Riethmacher, Torsten Wüstefeld, Michaela Miehe, Christian Trautwein, Dieter Riethmacher. Maid (GCIP) is involved in cell cycle control of hepatocytes. Hepatology 2007; 45(2): 404 doi: 10.1002/hep.21461
|
| 28 |
Mohamed Abd El‐Fattah, Mohamed Aboelmagd, Mohammed Elhamouly. Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population‐based study. United European Gastroenterology Journal 2017; 5(2): 227 doi: 10.1177/2050640616659024
|
| 29 |
Dina H. Ziada, Sherif El Sadany, Hanan Soliman, Sherief Abd-Elsalam, Marwa Salama, Nehad Hawash, Amal Selim, Manal Hamisa, Hala M. Elsabagh. Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study. Journal of the Egyptian National Cancer Institute 2016; 28(4): 257 doi: 10.1016/j.jnci.2016.06.001
|
| 30 |
Sotiria Bedreli, Katja Straub, Anne Achterfeld, Katharina Willuweit, Antonios Katsounas, Fuat Saner, Heiner Wedemeyer, Kerstin Herzer. The Effect of Immunosuppression on Coagulation After Liver Transplantation. Liver Transplantation 2019; 25(7): 1054 doi: 10.1002/lt.25476
|
| 31 |
Luca Ielasi, Enrico Fulco, Nicola Reggidori, Marco Domenicali, Francesco Giuseppe Foschi. Anabolic Androgenic Steroids and Hepatocellular Adenoma and Carcinoma: Molecular Mechanisms and Clinical Implications. Gastroenterology Insights 2024; 15(3): 599 doi: 10.3390/gastroent15030044
|
| 32 |
Darmadi Darmadi, Riska Habriel Ruslie, Cennikon Pakpahan. Association between serum midkine levels and tumor size in Indonesian hepatocellular carcinoma patients: a cross-sectional study. Romanian Journal of Internal Medicine 2022; 60(4): 229 doi: 10.2478/rjim-2022-0014
|
| 33 |
Sheng Chen, Zhiyuan Gong, Robert J. Letcher, Chunsheng Liu. Promotion effect of liver tumor progression in male kras transgenic zebrafish induced by tris (1, 3-dichloro-2-propyl) phosphate. Ecotoxicology and Environmental Safety 2020; 191: 110220 doi: 10.1016/j.ecoenv.2020.110220
|
| 34 |
Elizabeth R. M. Zunica, Elizabeth C. Heintz, Christopher L. Axelrod, John P. Kirwan. Obesity Management in the Primary Prevention of Hepatocellular Carcinoma. Cancers 2022; 14(16): 4051 doi: 10.3390/cancers14164051
|
| 35 |
Coskun Ozer Demirtas, Feyza Gunduz. Letter: Is female sex an independent predictor of favourable prognosis in hepatocellular carcinoma?. Alimentary Pharmacology & Therapeutics 2020; 52(11-12): 1765 doi: 10.1111/apt.16088
|
| 36 |
César Yaghi, Ala l Sharara, Paul Rassam, Rami Moucari, Khalil Honein, Joseph BouJaoude, Rita Slim, Roger Noun, Heitham Abdul-Baki, Mohamad Khalifeh, Sami Ramia, Raymond Sayegh. Hepatocellular carcinoma in Lebanon: Etiology and prognostic factors associated with short-term survival. World Journal of Gastroenterology 2006; 12(22): 3575-3580 doi: 10.3748/wjg.v12.i22.3575
|
| 37 |
John M. Lyons, Denise M. Danos, Lauren Maniscalco, Yong Yi, Xiao-Cheng Wu, Quyen D. Chu. Trends in hepatocellular carcinoma in Louisiana, 2005–2015. Dialogues in Health 2022; 1: 100041 doi: 10.1016/j.dialog.2022.100041
|
| 38 |
Özden ÖZDEMİR BAŞER, Nevin ORUÇ. HEPATOSELLÜLER KARSİNOMA TANILI HASTALARDA ETİYOLOJİ VE DEMOGRAFİK ÖZELLİKLER. Bozok Tıp Dergisi 2022; doi: 10.16919/bozoktip.1055425
|
| 39 |
Robert C. G. Martin, Matthew Woeste, Michael E. Egger, Charles R. Scoggins, Kelly M. McMasters, Prejesh Philips. Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma. Cancers 2023; 15(7): 1965 doi: 10.3390/cancers15071965
|
| 40 |
Junfang Ji, Jiong Shi, Anuradha Budhu, Zhipeng Yu, Marshonna Forgues, Stephanie Roessler, Stefan Ambs, Yidong Chen, Paul S. Meltzer, Carlo M. Croce, Lun-Xiu Qin, Kwan Man, Chung-Mau Lo, Joyce Lee, Irene O.L. Ng, Jia Fan, Zhao-You Tang, Hui-Chuan Sun, Xin Wei Wang. MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer. New England Journal of Medicine 2009; 361(15): 1437 doi: 10.1056/NEJMoa0901282
|
| 41 |
Jangmoo Byeon, Eung-Ho Cho, Sang Bum Kim, Dong Wook Choi. Extrahepatic recurrence of hepatocellular carcinoma after curative hepatic resection. Korean Journal of Hepato-Biliary-Pancreatic Surgery 2012; 16(3): 93 doi: 10.14701/kjhbps.2012.16.3.93
|
| 42 |
Wei‐Lun Liou, Terence J‐Y. Tan, Kaina Chen, George B‐B. Goh, Jason P‐E. Chang, Chee‐Kiat Tan. Gender survival differences in hepatocellular carcinoma: Is it all due to adherence to surveillance? A study of 1716 patients over three decades. JGH Open 2023; 7(5): 377 doi: 10.1002/jgh3.12910
|
| 43 |
Aleena Malik, Meghan P Jairam, Ronald Chow, Seyed A Mirshahvalad, Patrick Veit-Haibach, Charles B Simone. Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression. Future Oncology 2023; 19(4): 279 doi: 10.2217/fon-2022-0893
|
| 44 |
Hanna Kakish, Mohammed O. Suraju, Erik S. Davis, Abhinav Seth, Yong K. Kwon, Hassan Aziz. Liver resection is superior to tumor ablation in patients with multifocal hepatocellular carcinoma. Journal of Surgical Oncology 2024; 129(6): 1113 doi: 10.1002/jso.27599
|
| 45 |
Shen Li, Sarani Ghoshal, Mozhdeh Sojoodi, Gunisha Arora, Ricard Masia, Derek J. Erstad, Michael Lanuti, Yujin Hoshida, Thomas F. Baumert, Kenneth K. Tanabe, Bryan C. Fuchs. Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis. Journal of Gastrointestinal Surgery 2019; 23(1): 101 doi: 10.1007/s11605-018-4004-6
|
| 46 |
Chung-Yu Huang, Kien-Thiam Tan, Shiu-Feng Huang, Yen-Jung Lu, Yeh-Han Wang, Shu-Jen Chen, Ka-Po Tse. Study of sex-biased differences in genomic profiles in East Asian hepatocellular carcinoma. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01131-9
|
| 47 |
Xiwu Ouyang, Lei Yao, Guodong Liu, Shiqing Liu, Liansheng Gong, Yao Xiao. Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532–3p/RAB9A signal under hypoxia. Biochemical and Biophysical Research Communications 2021; 557: 26 doi: 10.1016/j.bbrc.2021.02.120
|
| 48 |
Chien‐Hung Chen, Wei‐Wen Su, Sheng‐Shun Yang, Ting‐Tsung Chang, Ken‐Sheng Cheng, Hans Hsienhong Lin, Shun‐Sheng Wu, Chuan‐Mo Lee, Chi‐Sin Changchien, Chien‐Jen Chen, Jin‐Chuan Sheu, Ding‐Shinn Chen, Sheng‐Nan Lu. Long‐term trends and geographic variations in the survival of patients with hepatocellular carcinoma: Analysis of 11 312 patients in Taiwan. Journal of Gastroenterology and Hepatology 2006; 21(10): 1561 doi: 10.1111/j.1440-1746.2006.04425.x
|
| 49 |
Ching-Wei Chang, Tsang-En Wang, Li-Tzong Chen, Wen-Hsiung Chang, Yi-Shing Leu, Yang-Kai Fan, Yu-Jan Chan. Unusual presentation of metastatic hepatocellular carcinoma in the nasal septum: a case report and review of the literature. Medical Oncology 2008; 25(3): 264 doi: 10.1007/s12032-007-9028-9
|
| 50 |
Tsang-En Wang, Ching-Wei Chang, Chia-Yuan Liu, Ming-Jen Chen, Cheng-Hsin Chu, Shee-Chan Lin, Horng-Yuan Wang. Clinical Characteristics of Hepatocellular Carcinoma in Elderly Patients. International Journal of Gerontology 2013; 7(2): 85 doi: 10.1016/j.ijge.2013.03.003
|
| 51 |
Cuiyun Wu, Yaosheng Luo, Yinghui Chen, Hongling Qu, Lin Zheng, Jie Yao. Development of a prognostic gene signature for hepatocellular carcinoma. Cancer Treatment and Research Communications 2022; 31: 100511 doi: 10.1016/j.ctarc.2022.100511
|
| 52 |
Riccardo Nevola, Giovanni Tortorella, Valerio Rosato, Luca Rinaldi, Simona Imbriani, Pasquale Perillo, Davide Mastrocinque, Marco La Montagna, Antonio Russo, Giovanni Di Lorenzo, Maria Alfano, Maria Rocco, Carmen Ricozzi, Klodian Gjeloshi, Ferdinando Carlo Sasso, Raffaele Marfella, Aldo Marrone, Loreta Anesti Kondili, Nicolino Esposito, Ernesto Claar, Domenico Cozzolino. Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma. Biology 2023; 12(7): 984 doi: 10.3390/biology12070984
|
| 53 |
Takashi Kaneko, Hirokazu Makishima, Masaru Wakatsuki, Yuichi Hiroshima, Toshiaki Matsui, Shigeo Yasuda, Naomi Nagatake Okada, Kenji Nemoto, Hiroshi Tsuji, Shigeru Yamada, Masaru Miyazaki. Carbon-ion radiotherapy for hepatocellular carcinoma with major vascular invasion: a retrospective cohort study. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12154-4
|
| 54 |
Puneeta Tandon, Guadalupe Garcia‐Tsao. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver International 2009; 29(4): 502 doi: 10.1111/j.1478-3231.2008.01957.x
|
| 55 |
Mohamed Abd El-Fattah. Hepatocellular carcinoma biology predicts survival outcome after liver transplantation in the USA. Indian Journal of Gastroenterology 2017; 36(2): 117 doi: 10.1007/s12664-017-0732-x
|
| 56 |
Sarita Ratana-Amornpin, Ratha-Korn Vilaichone, Muhammad Miftahussurur, Natsuda Aumpan, Kittipong Kaewkarnjanarat, Pongjarat Nun-anan, Soonthorn Chonprasertsuk, Sith Siramolpiwat, Patommatat Bhanthumkomol, Bubpha Pornthisarn, Tomohisa Uchida, Varocha Mahachai. Clinical Features and Overall Survival of Females with Hepatocellular Carcinoma: A Retrospective Study and Review of the Literature in the Association of Southeast Asian Nations. International Journal of Women's Health 2021; : 717 doi: 10.2147/IJWH.S311419
|
| 57 |
Ping-Ho Chen, Ying-Chu Lin, Hung-Pin Tu, Shang-Lun Chiang, Albert Min-Shan Ko, Chun-Lan Hsu, Yu-Fang Chang, Ying-Chin Ko. Important prognostic factors for the long-term survival of subjects with primary liver cancer in Taiwan: A hyperendemic area. European Journal of Cancer 2007; 43(6): 1076 doi: 10.1016/j.ejca.2007.01.022
|
| 58 |
Won Kim. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases. 2022; : 229 doi: 10.1007/978-981-19-0120-1_15
|
| 59 |
Lingxi Jiang, Qian Yan, Shuo Fang, Ming Liu, Yan Li, Yun‐Fei Yuan, Yan Li, Yinghui Zhu, Jiali Qi, Xiaodong Yang, Dora Lai Wan Kwong, Xin‐Yuan Guan. Calcium‐binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating extracellular signal‐regulated kinase signaling pathway. Hepatology 2017; 66(5): 1529 doi: 10.1002/hep.29312
|
| 60 |
Rania Sobhy Abou Khadrah, Mona Hassan Abedelmalik, Mohammed Abed Elhameed Alameldeen, Aly Aly Elbarbary. Hepatocellular carcinoma vascularization: CT angiography variations identifying arteries feeding the tumour. Egyptian Journal of Radiology and Nuclear Medicine 2023; 54(1) doi: 10.1186/s43055-023-01133-7
|
| 61 |
Yafei Zhang, Bicheng Zhang, Anran Zhang, Xiaohua Li, Jian Liu, Jie Zhao, Yong Zhao, Jianfei Gao, Dianchun Fang, Zhiguo Rao. IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells. Brazilian Journal of Medical and Biological Research 2012; 46(1): 32 doi: 10.1590/S0100-879X2012007500155
|
| 62 |
Bong Kyung Bae, Hee Chul Park, Jeong Il Yu, Gyu Sang Yoo, Dong Hyun Sinn, Moon Seok Choi, Joo Hyun Oh. Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.928119
|
| 63 |
Fabio Farinati, Adriana Sergio, Anna Giacomin, Maria Anna Di Nolfo, Paolo Del Poggio, Luisa Benvegnù, Gianludovico Rapaccini, Marco Zoli, Franco Borzio, Edoardo G. Giannini, Eugenio Caturelli, Franco Trevisani. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?. European Journal of Gastroenterology & Hepatology 2009; 21(10): 1212 doi: 10.1097/MEG.0b013e32831a86f8
|
| 64 |
Hyo-jae Lee, Jin Woong Kim, Young Hoe Hur, Sung Bum Cho, Byung Chan Lee, Byung Kook Lee, Eu Chang Hwang, Yong Soo Cho, Hyun Ju Seon. Conventional Chemoembolization Plus Radiofrequency Ablation versus Surgical Resection for Single, Medium-Sized Hepatocellular Carcinoma: Propensity-Score Matching Analysis. Journal of Vascular and Interventional Radiology 2019; 30(3): 284 doi: 10.1016/j.jvir.2018.09.030
|